Medical Facts
Research
Scientific evidence confirms Narhex Cross-Linked 10/1 NarElastin reduces the appearance of fine lines and wrinkles with regular use.
The Narhex Alpha Hydroxy Acid (AHA) formula exfoliates dry, dead skin cells to reveal a smoother and softer complexion, reducing the appearance of fine lines and wrinkles.
The formulation means there is no excessive skin peeling, increased sensitivity to the sun, or redness as a result of using Narhex AHA products.
After a four week (28 days) trial of Narhex Eye Cream
Overall 75 subjects experienced a 67% improvement in their coarse under-eye skin condition, such as coarse wrinkles and expression lines and wrinkles.
The same subjects had 76% improvement in fine skin condition, such as fine lines, pores and fine wrinkles.
Improvement of between a few percent to over 80% with most improved subjects showing a 10 to 40% net reduction of coarse and fine expression lines & wrinkles was experienced on a person-to-person basis.
Why moisturising your skin is important
Narhex Moisturiser Type 2 AHA removes the build-up of dead skin cells, which can act as a barrier to achieving the best possible results.For the ultimate results first apply Narhex AHA Moisturiser then the Facial Treatment 1% NarElastinTM and/or the Facial Lift 4% NarElastinTM + collagen.
3D scans of two moulds from under the eyes show differences in the depth of wrinkles
Results after 4 weeks of self treatment under-eyes of women and men excluding a temporary moisturising effect.There is a major reduction visible in the mould taken after Eye Cream 3% NarElastinTM was applied for 28 days.
Skin before using Eye CreamSkin after using Eye Cream
Independent Clinical Trials
Independent clinical trials have been conducted in three countries:
In Australia:
Dr Vyt Garnys (Project Leader - CETE)
Dr David Nurse (Consultant Dermatologist)
Royal Melbourne Hospital, Melbourne, Australia
In the United Kingdom:
Professor Ronald Marks (Professor of Dermatology)
Department of Medicine, Univeristy of Wales College of Medicine, Cardiff, Wales
In France:
Dr J P Cesarini (Senior Research Dermatologist)
Groupe De Recherche Foundation A Rothschild
